ESOMEPRAZOL Mepha cpr pell 20 mg 14 pce

7680625810135 CH-62581 A02BC05 04.99.0.

Active substances:

ESOMEPRAZOL Mepha cpr pell 20 mg 14 pce
ESOMEPRAZOL Mepha cpr pell 20 mg 14 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6258101
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, talcum, triethylis citras, hypromellosum, sacchari sphaerae corresp. saccharum max. 5.65 mg, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, polyvidonum K 29-32, macrogolum 6000, crospovidonum, natrii stearylis fumaras corresp. natrium 0.035 mg, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Esomeprazol-Mepha 20 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/11/2025
Patient information leaflet
Français
06/11/2025
Patient information leaflet
Italien
06/11/2025
Professional SmPC
Allemand
06/11/2025
Professional SmPC
Français
06/11/2025
Professional SmPC
Italien
06/11/2025

Detailed composition

Substance Quantity Type Category
esomeprazolum
20.0 MG Substance Wirkstoff (Principe actif)
esomeprazolum magnesicum dihydricum
- Substance WIZUS
acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum
- Substance HNIDK
talcum
- Substance HNIDK
triethylis citras
- Substance HNIDK
hypromellosum
- Substance HNIDK
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
magnesii stearas
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
glyceroli monostearas 40-55
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
polyvidonum K 29-32
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
crospovidonum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrium
0.035 MG Substance HBESI
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK

Reimbursement information

Public price
CHF 15.25
Specialties list
Yes
Generic
Yes
SL addition date: 01/06/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62581
Drug name
Esomeprazol-Mepha, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC05
Authorization status
Z
Dispensation category
B
First authorization
06/02/2014
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenblocker

Packaging details

Description (FR)
ESOMEPRAZOL Mepha cpr pell 20 mg 14 pce
Description (DE)
ESOMEPRAZOL Mepha Filmtabl 20 mg 14 Stk
Market launch
06/02/2014
Narcotic (BTM)
No

Original drug

Esomep i.v., Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 13.65
View original

Other packaging sizes

ESOMEPRAZOL Mepha cpr pell 20 mg 30 pce
30 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg 60 pce
60 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg 100 pce
100 TABL
View
ESOMEPRAZOL Mepha cpr pell 20 mg bte 100 pce
100 TABL
View
Buy us a coffee Explore the data